F012 | C1-Esterase Inhibitor | |
F218 | HEPATITIS B CORE ANTIBODY TOTAL | |
f218 | HEPATITIS B CORE ANTIBODY IGM | |
F158 | HEPATITIS B SURFACE ANTIBODY QUALITATIVE | |
F155 | HEPATITS B SURFACE ANTIGEN | |
F153 | HEPATITS A ANTIBODY TOTAL | |
F150 | Hepatitis A Antibody IGM | |
E100 | Protein Electrophoresis Serum | |
L170 | LAMOTRIGINE | |
L410 | TACROLIMUS | |
E144 | Mycoplasma Antibodies | |
E758 | ALDOSTERONE/RENIN ACTIVITY RATIO | |
L856 | ZINC, SERUM OR PLASMA | |
E759 | ALDOSTERONE | |
U001 | APOLIPOPROTEIN E (APOE) 2 MUTATIONS | |
F530 | CALPROTECTIN | |
E532 | FATTY ACIDS PROFILE ESSENTIAL (C12-C22) | |
E380 | LIPOPROTEIN A | |
F162 | PARVO B19 IGM | |
F161 | PARVO B19 IGG ABS | |
L893 | OPIATES SERUM OR PLASMA QUANTITATIVE | |
E439 | FREE T4 BY EQUILIBRIUM DIALYSIS | |
F802 | THYROGLOBULIN BY LC-MS/MS SERUM OR PLASMA | |
L405 | SIROLIMUS BY TANDEM MASS SPECTROMETRY | |
E842 | Metanephrines, Fractionated, 24hour | |